| Financial Year |
March 31 2023 |
| Monetary Funds |
1,356,328,353.94 |
| Held-for-trading Financial Assets |
250,518,336.95 |
| Notes Receivable |
253,467,429.41 |
| Accounts Receivable |
962,438,515.62 |
| Advances to Suppliers |
28,676,240.91 |
| Other Receivables |
4,416,637.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
589,948,477.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,459,966.94 |
| Total Current Assets |
3,504,253,958.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,826,853.63 |
| Investment Properties |
-- |
| Fixed Assetes |
700,913,684.65 |
| Under-construction Projects |
255,116,245.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
160,211,841.30 |
| R&D expenses |
-- |
| Goodwill |
139,442,597.72 |
| Long-Term Deferred and Prepaid Expenses |
19,438,370.64 |
| Deferred Income Tax Assets |
19,980,105.68 |
| Other Non-Current Assets |
5,846,118.34 |
| Sub-Total of Non-Current Assets |
1,516,152,089.17 |
| Total Assets |
5,020,406,048.16 |
| Short-Term Loans |
509,610,083.33 |
| Trading Financial liabilities |
1,983,906.25 |
| Notes Payable |
551,671,270.27 |
| Accounts Payable |
484,228,441.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,108,754.13 |
| Taxes Payable |
21,094,335.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,553,361.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,739,904.42 |
| Other Current Liabilities |
33,630,163.59 |
| Sub-Total of Current Liabilities |
1,713,280,675.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,595,149.23 |
| Deferred Income Tax Liabilities |
6,754,497.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,497,628.25 |
| Total Liabilities |
1,739,778,304.17 |
| Paid-In Capital(Or Share Stock) |
262,128,736.00 |
| Capital Surplus |
1,616,377,443.50 |
| Surplus Reserve |
133,051,019.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,043,660,508.73 |
| Minority Stockholder's Interest |
213,323,401.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,067,304,342.10 |
| Owner's Equity（Stockholder's Equity） |
3,280,627,743.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,020,406,048.16 |
